Ischemic heart disease is the most common cause of lethal ventricular arrhythmias and
sudden cardiac death (SCD). In patients who are at high risk after myocardial infarction …

Despite key advances in the clinical management of life-threatening ventricular arrhythmias,
culminating with the development of implantable cardioverter-defibrillators and catheter …

Cardiac arrhythmias remain a common challenge and are associated with significant
morbidity and mortality. Effective and safe rhythm control strategies are a primary, yet unmet …

Cardiac arrhythmias remain a common cause of death and disability. Antiarrhythmic drugs
(AADs) and antiarrhythmic agents remain a cornerstone of current cardiac arrhythmia …

This book incorporates the most up-to date information related to mechanisms and treatment
of cardiac arrhythmia. Many of the topics discussed in this text reflect very recently …

Maintenance of normal cardiac rhythm requires coordinated activity of ion channels and
transporters that allow well-ordered propagation of electrical impulses across the …

Ventricular tachyarrhythmias are common consequences of coronary artery disease. During
the prehospital phase of acute myocardial infarction (MI), ischemia-induced …

The underlying mechanisms behind cardiac arrhythmias are described in this manuscript. In
clinical practice, significant arrhythmias are unpredictable, and under some conditions …

Heart failure affects nearly 6 million Americans, with a half-million new cases emerging each
year. Whereas up to 50% of heart failure patients die of arrhythmia, the diverse mechanisms …

Arrhythmogenic cardiomyopathy is a genetic disorder characterized by the risk of life-
threatening arrhythmias, myocardial dysfunction and fibrofatty replacement of myocardial …